Impact of estrogen receptor alpha and beta agonists on delayed alternation in middle-aged rats

• Published in: Hormones and behavior Vol. 58; no. 5; pp. 878 - 890
• Main Authors: Neese, Steven L., Korol, Donna L., Katzenellenbogen, John A., Schantz, Susan L.
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier Inc 01.11.2010; Elsevier; Elsevier BV
• Subjects: Aging; Aging - drug effects; Aging - physiology; Aging - psychology; Animal behavior; Animal cognition; Animals; Behavior, Animal - drug effects; Behavior, Animal - physiology; Behavioral psychophysiology; Biological and medical sciences; Cognition; Cognition - drug effects; Cognition - physiology; Conditioning, Operant - drug effects; Drug Evaluation, Preclinical; DSA; Estrogen receptor agonists; Estrogen Receptor alpha - agonists; Estrogen Receptor beta - agonists; Estrogens; Female; Females; Fundamental and applied biological sciences. Psychology; Hormones and behavior; Memory, Short-Term - drug effects; Memory, Short-Term - physiology; Nitriles - pharmacology; Phenols; Propionates - pharmacology; Psychology. Psychoanalysis. Psychiatry; Psychology. Psychophysiology; Pyrazoles - pharmacology; Rats; Rats, Long-Evans; Rodents; Selective Estrogen Receptor Modulators - pharmacology; Task Performance and Analysis; Working memory; Aging; Cognition; DSA; Working memory; Estrogen receptor agonists; Human; Estrogen receptor; Agonist; Senescence; Rat; Rodentia; Vertebrata; Mammalia; Animal; Adult
• ISSN: 0018-506X; 1095-6867
• DOI: 10.1016/j.yhbeh.2010.08.017

Estrogens act in the adult brain to modulate cognition, enhancing performance on some learning tests and impairing performance on others. Our previous research has revealed an impairing effect of chronic 17β-estradiol treatment in young and aged rats on a prefrontally-mediated working memory task, delayed spatial alternation (DSA). Little is known about the mechanisms of these impairing effects. The current study examined the effects of selective estrogen receptor (ER) α or ERβ activation on DSA performance in middle-aged female rats. Ovariectomized 12 month old Long–Evans (LE) rats were treated by subcutaneous injection with the ERα agonist propyl pyrazole triol (PPT) or the ERβ agonist diarylpropionitrile (DPN) at 0.02, 0.08, or 0.20 mg/kg/day, or with oil vehicle and tested on an operant variable delay DSA task. A 17β-estradiol group (10% in cholesterol) was included as a positive control group. We replicated our previous finding of a 17β-estradiol induced deficit on DSA performance and this effect was paralleled by low dose (0.02 mg/kg/day) DPN treatment. Higher doses of DPN failed to produce a significant change in performance. The highest dose of PPT (0.20 mg/kg/day) also impaired performance, but this effect was subtle and limited to the longest delay during the final block of testing. These data confirm our earlier findings that chronic 17β-estradiol treatment has an impairing effect on the DSA task, and suggest that ERβ activation may underlie the deficit. ►17β-estradiol impaired delayed spatial alternation performance (DSA) in female rats. ►The estrogen receptor (ER)β agonist diarylpropionitrile also impairs DSA performance. ►The ERα agonist propyl pyrazole triol had limited effects on DSA performance.► ERβ activation may underlie the 17β-estradiol deficit on DSA performance.